资讯

In an exclusive interview, Sally Susman, a pioneer in corporate comms, recounts finding out that Pfizer's COVID-19 vaccine ...
To date, over a billion adults and children around the world have received the Pfizer-BioNTech COVID-19 vaccine, which continues to demonstrate a favorable safety and efficacy profile supported by ...
A promising new COVID-19 vaccine candidate developed by researchers at the Centenary Institute and the University of Sydney ...
Dan Peer, a global pioneer in mRNA drug development and director of the Laboratory of Precision NanoMedicine ... Research and Tel Aviv University is an mRNA-based vaccine delivered via lipid ...
COVID-19 trends also depend on the emergence and spread of new variants. The latest, including NB.1.8.1, are getting better ...
The company also said it’s going to “de-prioritize” development of the combination flu and Covid-19 vaccine for people under the age of 50, instead focusing on advancing it for older adults ...
Despite mistrust, Native Americans’ participation in vaccine development proves vital. ... the research on Pfizer’s COVID-19 vaccine included data on Native Americans’ reactions to the vaccine.